Vascular Pharmacology 81 Acute Cardiovascular Care 6: Max Smith, Vindhya B. In Panel C, the number at risk includes all patients who were alive regardless of whether a nonfatal event had occurred during the first 3 days after randomization and had not withdrawn consent for follow-up.
Hillegass, Lindsay Hines, Richard B. Fatima Rodriguez, Robert W. Medical Science Monitor 21 CrossRef Kevin P. Internal and Emergency Medicine 10 Diabetes and Vascular Disease Research Clopidogrel for coronary stenting: An independent data monitoring committee monitored the safety and efficacy of the study drugs. Jose Carlos Nicolau, Deepak L. Wilke, James Willig, Richard Y.
Winters and Brown, being employees of and having an equity interest in Eli Lilly; Dr. Anticoagulation and Hemostasis in Neurosurgery, Pokov, Moo Hyun Kim. Expert Opinion on Pharmacotherapy Sinnaeve, Frans Van de Werf.
Coronary Artery Disease, Current Cardiovascular Risk Reports 9. Significance of occult gastrointestinal bleeding during anticoagulation therapy. European Heart Journal 36 Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes.
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. Bridget Paravattil, Hazem Elewa. N Engl J Med. BJA Education 16 David Erlinge, Paul A.